New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 16, 2013
10:08 EDTAA, VLTR, RIG, DANG, CL, STM, INO, RRGB, PT, JWN, NOR, GIS, AV, MXIMOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alcoa (AA) downgraded to Underperform from Neutral at BofA/Merrill... Aviva (AV) downgraded to Neutral from Outperform at Exane BNP Paribas... General Mills (GIS) downgraded to Underperform from Hold at Jefferies... Noble Energy (NBL) downgraded to Buy from Strong Buy at ISI Group... Noranda Aluminum (NOR) downgraded to Underperform from Neutral at BofA/Merrill... Nordstrom (JWN) downgraded to Neutral from Buy at Sterne Agee... Portugal Telecom (PT) downgraded to Neutral from Buy at Goldman... Red Robin (RRGB) downgraded to Neutral from Buy at B. Riley... STMicroelectronics (STM) downgraded to Underweight from Neutral at HSBC... Inovio (INO) downgraded to Hold from Buy at Aegis... Colgate-Palmolive (CL) downgraded to Hold from Buy at Argus... Dangdang (DANG) downgraded to Equal Weight from Overweight at Morgan Stanley... Noble Energy (NBL) downgraded at ISI Group... Transocean (RIG) downgraded to Underweight from Overweight at Johnson Rice... Volterra (VLTR) downgraded to Sell from Neutral at B. Riley... Maxim Integrated (MXIM) downgraded to Equal Weight from Overweight at Morgan Stanley.
News For AA;AV;GIS;NOR;JWN;PT;RRGB;INO;STM;CL;DANG;RIG;VLTR;MXIM From The Last 14 Days
Check below for free stories on AA;AV;GIS;NOR;JWN;PT;RRGB;INO;STM;CL;DANG;RIG;VLTR;MXIM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2014
09:20 EDTINOInovio's VGX-3100 for cervical dysplasia shows positive Phase II results
Inovio Pharmaceuticals announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 associated with human papillomavirus types 16 or 18. Treatment with VGX-3100 resulted in histopathological regression of CIN2/3 to CIN1 or no disease, meeting the study's primary endpoint. The trial demonstrated clearance of HPV in conjunction with regression of cervical lesions. Robust T-cell activity was detected in subjects who received VGX-3100 compared to those who received placebo.
05:16 EDTSTMSTMicroelectronics sees Q3 revenue up about 3%
Subscribe for More Information
05:12 EDTSTMSTMicroelectronics reports Q2 adjusted EPS 11c, consensus 3c
Subscribe for More Information
July 22, 2014
16:00 EDTAAOptions Update; July 22, 2014
Subscribe for More Information
July 21, 2014
10:18 EDTPTCVM could take weeks to examine new Oi-PT merger deal, Reuters says
Brazil securities watchdog CVM could need weeks to fully examine the new terms of a merger agreement between Grupo Oi and Portugal Telecom which require Portugal Telecom to set aside more treasury-held shares, according to Reuters, citing comments from former CVM president Maria Helena Santana. Reference Link
08:41 EDTMXIMMaxim Integrated Q1 guidance likely to beat expectations, says Pacific Crest
Pacific Crest expects Maxim's Q1 EPS guidance to surpass expectations, driven by increased revenue from Apple's (AAPL) iPhone 6 and iWatch. The firm recommends buying the stock, as it thinks the shares have a number of positive catalysts including content share gains in mobility and increasing automotive revenue exposure. The firm keeps a $44 price target and Outperform rating on the shares.
07:11 EDTINOInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
July 17, 2014
16:13 EDTAAHP appoints Whitman Chairman, Alcoa's Kleinfeld joins board
Subscribe for More Information
09:40 EDTAAActive equity options trading on open
Subscribe for More Information
July 16, 2014
06:24 EDTPTPortugal Telecom, Oi reaffirm support for business combination
Subscribe for More Information
July 15, 2014
14:59 EDTSTMSynaptics shares should be bought on weakness, says Cowen
Subscribe for More Information
10:37 EDTAAOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTMXIMOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Adecogro (AGRO) downgraded to Underperform from Neutral at BofA/Merrill... Campbell Soup (CPB) downgraded to Sell from Neutral at Goldman... Credicorp (BAP) downgraded to Neutral from Overweight at JPMorgan... El Paso Pipeline (EPB) downgraded to Neutral from Buy at Citigroup... Kellogg (K) downgraded to Sell from Neutral at Goldman... Kodiak Oil & Gas (KOG) downgraded to Market Perform from Outperform at BMO Capital... Lexmark (LXK) downgraded at Bernstein... Maxim Integrated (MXIM) downgraded to Equal Weight from Overweight at Barclays... Republic Airways (RJET) downgraded to Underperform from Neutral at BofA/Merrill... Sasol (SSL) downgraded to Neutral from Buy at Citigroup... Time Warner (TWX) downgraded to Equal Weight from Overweight at Evercore.
10:00 EDTRIGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:51 EDTGISGeneral Mills inaugurates facility in China
Subscribe for More Information
08:50 EDTGISGeneral Mills expects double-digit net sales growth from Greater China this year
Subscribe for More Information
08:32 EDTRRGBRed Robin completes acquisition of 32 franchised restaurants for $40M
Subscribe for More Information
07:16 EDTPTPortugal Telecom may be hit by default from Espirito Santo investment, WSJ says
Portugal Telecom could be hit by a default from an investment it made with Espirito Santo International, which was found to be in a "seriously financial condition" by the country's central bank, the Wall Street Journal reports. PT previously disclosed that it had $1.22B in commercial paper from Espirito Santo's Rioforte. Reference Link
06:41 EDTRIGTransocean upgraded to Market Perform from Underperform at BMO Capital
BMO upgraded the offshore drillers to Market Perform from Underperform citing valuation, reduced expectations, and a slow resumption in activity. Price target raised to $43 from $36.
05:28 EDTMXIMMaxim Integrated downgraded to Equal Weight from Overweight at Barclays
Barclays downgraded Maxim Integrated to Equal Weight citing limited upside to estimates and the move higher in shares since its upgrade. The firm keeps a $35 price target for the stock.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use